Check Glucotrack Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.8M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
26379900.00%
Compare market cap, revenue, PE, and other key metrics of Glucotrack Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $6.8M | NA | NA | 0.00% | |
BUY | $155.5B | 98.45% | 60.57 | 28.51% | |
BUY | $39.8B | 59.82% | 28.57 | 27.22% | |
BUY | $38.5B | 31.2% | 35.74 | 10.70% | |
BUY | $18.5B | -7.59% | 38.36 | 16.48% |
The Glucotrack Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Glucotrack Inc investment value today
Current value as on today
₹5,151
Returns
Returns from Glucotrack Inc Stock
Dollar Returns*
₹4,953 (+4.95%)
Investment in Glucotrack Inc Shares on INDmoney has grown by 1107.69% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:1107.69% versus previous 30 day period
Search interest for Glucotrack Inc Stock has increased by 243% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:243% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 12 September
Fri, 05:58 PM
-GlucoTrack announces a $20 million share sale agreement, boosting stock by 150% amid heavy trading.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Intuitive Surgical, Inc. has given 21.2% return, outperforming this stock by 121.1%
Against Peers
In the last 1 year, Resmed Inc. has given 11.8% return, outperforming this stock by 111.6%
Price Dip
In the last 7 days, GCTK stock has moved down by -28.7%
Organisation | Glucotrack Inc |
Headquarters | 301 Route 17 North, Rutherford, NJ, United States, 07070 |
CEO | Mr. Paul V. Goode Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Paul V. Goode Ph.D. | CEO, President & Director |
Mr. Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board |
Mr. David Malka BA | Co-Founder |
Mr. Peter C. Wulff | CFO, Treasurer & Secretary |
Mr. Vincent Wong | Vice President of Operations |
Mr. Mark Tapsak Ph.D. | Chief Scientific Officer |
Ms. Drinda Benjamin | Vice President of Marketing |
Glucotrack Inc share price today is $6.9 as on at the close of the market. Glucotrack Inc share today touched a day high of $7.76 and a low of $6.84.
Glucotrack Inc share touched a 52 week high of $3,576 on and a 52 week low of $4.22 on . Glucotrack Inc stock price today i.e. is closed at $6.9,which is 99.81% down from its 52 week high and 63.51% up from its 52 week low.
Glucotrack Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Glucotrack Inc (GCTK) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Glucotrack Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Glucotrack Inc share’s latest price of $6.9 as on September 19, 2025 at 1:29 am IST, you will get 1.4493 shares of Glucotrack Inc. Learn more about
fractional shares .